Vascular Surgery Division

Related News

Known nationally as a leader in cardiovascular care, Baystate Medical Center was one of only 30 institutions in the U.S. and Europe invited to take part in an important trial seeking Food and Drug Administration (FDA) approval for a new technology to treat aortic disease, a novel device that could benefit a wider group of patients, say the hospital’s vascular surgeons.